Treatment implications of T cell DNA damage in anti-tumor immunity

Area of Science:

• Immunology
• Oncology
• Molecular Biology

Background:

• T cell activity is crucial for immunotherapy and tumor control.
• DNA damage in T cells significantly influences their therapeutic potential.
• DNA damage serves as both a predictive biomarker and a druggable target in cancer therapy.

Purpose of the Study:

• To review the origins and consequences of DNA damage in T cells.
• To assess the therapeutic implications of T cell DNA damage in the tumor microenvironment and during cancer treatment.
• To highlight the dual role of DNA damage as a biomarker and therapeutic target.

Main Methods:

• Literature review of current research on T cell DNA damage.
• Elucidation of mechanisms linking DNA damage to T cell fate and function.
• Analysis of therapeutic strategies involving DNA damage modulation.

Main Results:

• DNA damage dynamics are a key factor in T cell function and therapeutic response.
• Modulating DNA damage in T cells can enhance anti-tumor efficacy.
• T cell DNA damage has implications for patient stratification and treatment design.

Conclusions:

• Integrating T cell DNA damage response into patient stratification and trial design is essential.
• Optimizing genotoxic therapies and immunotherapy combinations can improve durable responses and minimize immune toxicity.
• Targeting DNA damage offers a promising strategy to enhance cancer immunotherapy.